Log in
NYSE:CVS

CVS Health Stock Forecast, Price & News

$58.14
-0.73 (-1.24 %)
(As of 09/22/2020 12:00 AM ET)
Add
Compare
Today's Range
$58.09
Now: $58.14
$59.23
50-Day Range
$57.00
MA: $62.23
$65.71
52-Week Range
$52.04
Now: $58.14
$77.03
Volume6.82 million shs
Average Volume8.93 million shs
Market Capitalization$76.09 billion
P/E Ratio9.24
Dividend Yield3.40%
Beta0.67
CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services. The company's Retail/LTC segment sells prescription drugs and general merchandise, such as over-the-counter drugs, beauty products, cosmetics, and personal care products, as well as provides health care services through its MinuteClinic walk-in medical clinics. Its Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, medical management, Medicare plans, PDPs, Medicaid health care management services, workers' compensation administrative services, and health information technology products and services. The company's customers include employers, insurance companies, unions, government employee groups, health plans, Medicare Part D prescription drug plans, Medicaid managed care plans, plans offered on public health insurance exchanges and private health insurance exchanges, other sponsors of health benefit plans, individuals, college students, workers, labor groups, and expatriates. As of December 31, 2018, it had approximately 40 leased on-site pharmacies, 25 leased retail specialty pharmacy stores, 20 specialty mail order pharmacies, and 90 branches for infusion and enteral services; and 9,900 retail locations and 1,100 MinuteClinic locations, as well as operated an online retail pharmacy Websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
Read More
CVS Health logo

Beat the Market (BTM) Rank

Analyst Opinion: 4.5Community Rank: 3.2Dividend Strength: 2.5Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.61 out of 5 stars


Industry, Sector and Symbol

Industry Drug stores & proprietary stores
Sub-IndustryDrug Retail
CUSIP12665010
Phone401-765-1500

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$256.78 billion
Cash Flow$10.22 per share
Book Value$49.33 per share

Profitability

Net Income$6.63 billion

Miscellaneous

Employees290,000
Outstanding Shares1,308,703,000
Market Cap$76.09 billion
Next Earnings Date11/4/2020 (Estimated)
OptionableOptionable
$58.14
-0.73 (-1.24 %)
(As of 09/22/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CVS News and Ratings via Email

Sign-up to receive the latest news and ratings for CVS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











CVS Health (NYSE:CVS) Frequently Asked Questions

How has CVS Health's stock been impacted by COVID-19?

CVS Health's stock was trading at $61.31 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CVS stock has decreased by 5.2% and is now trading at $58.14.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of CVS Health?

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 3 hold ratings, 13 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for CVS Health
.

When is CVS Health's next earnings date?

CVS Health is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for CVS Health
.

How were CVS Health's earnings last quarter?

CVS Health Corp (NYSE:CVS) released its quarterly earnings results on Wednesday, August, 5th. The pharmacy operator reported $2.64 EPS for the quarter, beating the consensus estimate of $1.93 by $0.71. The pharmacy operator had revenue of $65.30 billion for the quarter, compared to the consensus estimate of $64.29 billion. CVS Health had a net margin of 3.13% and a return on equity of 16.32%. CVS Health's revenue was up 2.9% compared to the same quarter last year. During the same quarter last year, the firm earned $1.89 EPS.
View CVS Health's earnings history
.

How often does CVS Health pay dividends? What is the dividend yield for CVS Health?

CVS Health announced a quarterly dividend on Wednesday, July 8th. Stockholders of record on Thursday, July 23rd will be paid a dividend of $0.50 per share on Monday, August 3rd. This represents a $2.00 annualized dividend and a yield of 3.44%. The ex-dividend date is Wednesday, July 22nd.
View CVS Health's dividend history
.

What guidance has CVS Health issued on next quarter's earnings?

CVS Health issued an update on its FY20 earnings guidance on Tuesday, September, 15th. The company provided EPS guidance of $7.14-7.27 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $7.23.

What price target have analysts set for CVS?

18 Wall Street analysts have issued 12 month price objectives for CVS Health's stock. Their forecasts range from $66.00 to $104.00. On average, they anticipate CVS Health's share price to reach $81.94 in the next twelve months. This suggests a possible upside of 40.9% from the stock's current price.
View analysts' price targets for CVS Health
.

Are investors shorting CVS Health?

CVS Health saw a increase in short interest in July. As of July 31st, there was short interest totaling 19,910,000 shares, an increase of 8.2% from the July 15th total of 18,400,000 shares. Based on an average daily trading volume, of 7,350,000 shares, the days-to-cover ratio is presently 2.7 days.
View CVS Health's Short Interest
.

Who are some of CVS Health's key competitors?

What other stocks do shareholders of CVS Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CVS Health investors own include AT&T (T), Walt Disney (DIS), Johnson & Johnson (JNJ), Cisco Systems (CSCO), NVIDIA (NVDA), AbbVie (ABBV), Verizon Communications (VZ), Intel (INTC), Home Depot (HD) and Alibaba Group (BABA).

Who are CVS Health's key executives?

CVS Health's management team includes the following people:
  • Mr. Larry J. Merlo, Pres, CEO & Director (Age 63)
  • Ms. Eva C. Boratto, Exec. VP & CFO (Age 52)
  • Mr. Jonathan C. Roberts, Exec. VP & COO (Age 63)
  • Mr. Thomas Michael Moriarty, Exec. VP, Chief Policy & External Affairs Officer and Gen. Counsel (Age 55)
  • Mr. Derica W. Rice, Exec. VP & Pres of CVS Caremark (Age 54)

What is CVS Health's stock symbol?

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

Who are CVS Health's major shareholders?

CVS Health's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (8.19%), BlackRock Inc. (7.42%), FMR LLC (2.11%), Nordea Investment Management AB (1.42%), Bank of New York Mellon Corp (1.01%) and Charles Schwab Investment Management Inc. (0.87%). Company insiders that own CVS Health stock include Alan Lotvin, C David Brown II, David M Denton, David W Dorman, Edward J Ludwig, Eva C Boratto, James David Clark, Jonathan C Roberts, Joshua Matthew Flum, Karen S Lynch, Larry J Merlo, Lisa Bisaccia, Troyen A Brennan and Vost Collin.
View institutional ownership trends for CVS Health
.

Which institutional investors are selling CVS Health stock?

CVS stock was sold by a variety of institutional investors in the last quarter, including Charles Schwab Investment Management Inc., Nuveen Asset Management LLC, State of Tennessee Treasury Department, Toronto Dominion Bank, Macquarie Group Ltd., Bank of New York Mellon Corp, FMR LLC, and Marshall Wace North America L.P.. Company insiders that have sold CVS Health company stock in the last year include James David Clark, Jonathan C Roberts, Joshua Matthew Flum, Karen S Lynch, Larry J Merlo, and Troyen A Brennan.
View insider buying and selling activity for CVS Health
.

Which institutional investors are buying CVS Health stock?

CVS stock was bought by a variety of institutional investors in the last quarter, including Nordea Investment Management AB, AQR Capital Management LLC, State of Michigan Retirement System, BlackRock Inc., Bank of Nova Scotia, LSV Asset Management, Ensign Peak Advisors Inc, and BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp. Company insiders that have bought CVS Health stock in the last two years include Alan Lotvin, C David Brown II, David W Dorman, and Edward J Ludwig.
View insider buying and selling activity for CVS Health
.

How do I buy shares of CVS Health?

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is CVS Health's stock price today?

One share of CVS stock can currently be purchased for approximately $58.14.

How big of a company is CVS Health?

CVS Health has a market capitalization of $76.09 billion and generates $256.78 billion in revenue each year. The pharmacy operator earns $6.63 billion in net income (profit) each year or $7.08 on an earnings per share basis. CVS Health employs 290,000 workers across the globe.

What is CVS Health's official website?

The official website for CVS Health is www.cvshealth.com.

How can I contact CVS Health?

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]

This page was last updated on 9/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.